June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
A novel approach for remote monitoring of European exudative AMD patients using macular thickness maps
Author Affiliations & Notes
  • Ian Raden
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Emilie Jomaa
    Service d'ophtalmologie, Centre Hospitalier Universitaire de Bordeaux, France
    INSERM, BPH, UMR1219, F-33000, Universite de Bordeaux, Bordeaux, France
  • Mahsa Darvishzadeh Varcheie
    Carl Zeiss Meditec, Inc., Dublin, California, United States
  • Diane Levesque
    Service d'ophtalmologie, Centre Hospitalier Universitaire de Bordeaux, France
    INSERM, BPH, UMR1219, F-33000, Universite de Bordeaux, Bordeaux, France
  • Jean-Francois Korobelnik
    Service d'ophtalmologie, Centre Hospitalier Universitaire de Bordeaux, France
    INSERM, BPH, UMR1219, F-33000, Universite de Bordeaux, Bordeaux, France
  • Footnotes
    Commercial Relationships   Ian Raden Carl Zeiss Meditec, Inc., Code E (Employment); Emilie Jomaa None; Mahsa Darvishzadeh Varcheie Carl Zeiss Meditec, Inc., Code E (Employment); Diane Levesque None; Jean-Francois Korobelnik Carl Zeiss Meditec, Inc., Code C (Consultant/Contractor)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 3419. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ian Raden, Emilie Jomaa, Mahsa Darvishzadeh Varcheie, Diane Levesque, Jean-Francois Korobelnik; A novel approach for remote monitoring of European exudative AMD patients using macular thickness maps. Invest. Ophthalmol. Vis. Sci. 2023;64(8):3419.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : OCT has been widely adopted as the gold standard for retinal structural visualization, but analysis of entire OCT volumes can be time-consuming and difficult to integrate in a telehealth workflow. In this retrospective study, we compared the ability to detect changes using macular thickness maps (MTMs) alone with the ability to detect changes using the entire OCT review station, to determine if MTMs alone could accurately predict recurrent exudation in patients with exudative age-related macular degeneration (eAMD).

Methods : Retrospective data from 44 eyes of 31 European patients with eAMD imaged using CIRRUSTM HD-OCT 5000 (ZEISS, Dublin, CA), over 7 consecutive visits (a period of ≥ 2 years), were analyzed. Patients in this study were placed under a treat-and-extend protocol and imaged using a macula centered 6x6 mm (512x128 pixels) OCT scan. Three graders (retina specialists) reviewed two consecutive images that were assumed to be acquired at the patients’ home. Graders were asked to determine if there were changes that warranted a full clinical assessment after viewing two consecutive scans using one of the two data sets: MTMs alone (Figure 1) or using the entire CIRRUS review station to evaluate all the information contained in the OCT scans.

Results : A total of 257 pairs of images were reviewed by each grader for each exercise. The consensus ground truth was reached by the graders using a CIRRUS review station to evaluate all the information contained within the OCT scans. For the 257 image pairs, the majority recommended clinical assessment was warranted in 61 cases. When comparing the majority agreement on the MTMs exercise with the ground truth, there was 83.27% agreement. The inter-grader agreement between all 3 graders when viewing MTMs alone was 81.32% and the inter-grader agreement between all 3 graders when viewing with the entire review station was 79.77%. The Fleiss Kappa was highest when using thickness maps alone, and both exercises resulted in a substantial level of agreement.

Conclusions : This study demonstrates that in European eAMD patients, MTMs alone may be a useful tool in determining whether to recall if monitoring patients remotely.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×